The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 18 Dec 2002
doi: 10.1242/jcs.00286
Research Article
VEGF expression in human macrophages is NF-
B-dependent: studies using adenoviruses expressing the endogenous NF-
B inhibitor I
B
and a kinase-defective form of the I
B kinase 2
Serafim Kiriakidis*,
Evangelos Andreakos,
Claudia Monaco,
Brian Foxwell,
Marc Feldmann,
and
Ewa Paleolog
* Author for correspondence (e-mail: s.kiriakidis{at}ic.ac.uk)
Vascular endothelial growth factor (VEGF) is the most endothelial cell-specific angiogenic factor characterised to date, and it is produced by a variety of cell types. In macrophages, VEGF has been shown to be upregulated by the inflammatory mediator lipopolysaccharide (LPS) and by engagement of CD40 by CD40 ligand (CD40L). Because LPS and CD40L activate nuclear factor-
B (NF-
B) in monocytes, we investigated in this study whether VEGF production in macrophages, when stimulated with either LPS or CD40L, is NF-
B-dependent. We used adenoviral constructs over-expressing either I
B
(AdvI
B
), the endogenous inhibitor of NF-
B, or a kinase-defective mutant of IKK-2 (AdvIKK-2dn), an upstream activator of I
B
, to infect normal human monocyte-derived macrophages. We observed that LPS-induced production of VEGF in human macrophages was almost completely inhibited (>90%) following adenoviral transfer of I
B
. In addition, we observed significant inhibition of the CD40L-induced VEGF production in macrophages following infection with AdvI
B
. Expression of IKK-2dn in macrophages decreased VEGF production in response to LPS or CD40L by approximately 50%, suggesting that in addition to IKK-2, other kinases might be involved in NF-
B activation. These results show for the first time that VEGF production in human macrophages is NF-
B dependent. NF-
B regulates many of the genes involved in immune and inflammatory responses, and our study adds the angiogenic cytokine VEGF to the list of NF-
B-dependent cytokines.
This article has been cited by other articles:

|
 |

|
 |
 
M.-C. Lee, S.-C. Wei, J.-J. Tsai-Wu, C. H. H. Wu, and P.-N. Tsao
Novel PKC signaling is required for LPS-induced soluble Flt-1 expression in macrophages
J. Leukoc. Biol.,
September 1, 2008;
84(3):
835 - 841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Mizukami, Y. Kohgo, and D. C. Chung
Hypoxia Inducible Factor-1 Independent Pathways in Tumor Angiogenesis
Clin. Cancer Res.,
October 1, 2007;
13(19):
5670 - 5674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gonzalez-Ramos, J. Donnez, S. Defrere, I. Leclercq, J. Squifflet, J.-C. Lousse, and A. Van Langendonckt
Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis
Mol. Hum. Reprod.,
July 1, 2007;
13(7):
503 - 509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Ray, A. Shakya, and A. Ray
Vascular Endothelial Growth Factor Expression in Arthritic Joint Is Regulated by SAF-1 Transcription Factor
J. Immunol.,
February 1, 2007;
178(3):
1774 - 1782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Mader, D. Smyth, J. Marshall, and D. W. Hoskin
Bovine Lactoferricin Inhibits Basic Fibroblast Growth Factor- and Vascular Endothelial Growth Factor165-Induced Angiogenesis by Competing for Heparin-Like Binding Sites on Endothelial Cells
Am. J. Pathol.,
November 1, 2006;
169(5):
1753 - 1766.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. T. Stathopoulos, Z. Zhu, M. B. Everhart, I. Kalomenidis, W. E. Lawson, S. Bilaceroglu, T. E. Peterson, D. Mitchell, F. E. Yull, R. W. Light, et al.
Nuclear Factor-{kappa}B Affects Tumor Progression in a Mouse Model of Malignant Pleural Effusion
Am. J. Respir. Cell Mol. Biol.,
February 1, 2006;
34(2):
142 - 150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fujioka, J. Niu, C. Schmidt, G. M. Sclabas, B. Peng, T. Uwagawa, Z. Li, D. B. Evans, J. L. Abbruzzese, and P. J. Chiao
NF-{kappa}B and AP-1 Connection: Mechanism of NF-{kappa}B-Dependent Regulation of AP-1 Activity
Mol. Cell. Biol.,
September 1, 2004;
24(17):
7806 - 7819.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Correa, V. Tergaonkar, J. K. Ng, I. Dubova, J. C. Izpisua-Belmonte, and I. M. Verma
Characterization of NF-{kappa}B/I{kappa}B Proteins in Zebra Fish and Their Involvement in Notochord Development
Mol. Cell. Biol.,
June 15, 2004;
24(12):
5257 - 5268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Monaco, E. Andreakos, S. Kiriakidis, C. Mauri, C. Bicknell, B. Foxwell, N. Cheshire, E. Paleolog, and M. Feldmann
Canonical pathway of nuclear factor {kappa}B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis
PNAS,
April 13, 2004;
101(15):
5634 - 5639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Walczak, S. B. Joseph, B. A. Laffitte, A. Castrillo, L. Pei, and P. Tontonoz
Transcription of the Vascular Endothelial Growth Factor Gene in Macrophages Is Regulated by Liver X Receptors
J. Biol. Chem.,
March 12, 2004;
279(11):
9905 - 9911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Monaco and E. Paleolog
Nuclear factor {kappa}B: a potential therapeutic target in atherosclerosis and thrombosis
Cardiovasc Res,
March 1, 2004;
61(4):
671 - 682.
[Abstract]
[Full Text]
[PDF]
|
 |
|
© The Company of Biologists Ltd 2002